Clinical Trial Management System Market Research Report: By Type (Enterprise CTMS and On-Site CTMS), Delivery Model (Web-Based [Hosted CTMS], Licensed Enterprise, Cloud-Based CTMS [SaaS]), Component (Software, Service and Hardware), End-User (Pharmaceutical and Biopharmaceutical Companies, Medical Device Manufacturers, Contract Research Organizations and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2030
ID: MRFR/HCIT/1522-HCR | February 2023 | Region: Global | 90 Pages
Speak to Analyst
Request a Free Sample
Clinical trial management system market
The clinical trial management system market is expected to grow at CAGR of 13.4% to reach USD 3.72 billion during the forecast period 2022-2030
$3.72 Billion
13.4%%
North America
2022-2030
Clinical Trial Management System Market Overview
The clinical trial management system market is expected to gain a market value of USD 3,720 million by 2030 at a CAGR of 13.4% from 2022-2030.
The clinical trial management system is an important software system for efficiently planning, managing, and tracking clinical research portfolios, along with contact information, tracking deadlines, and milestones of the participants. The study team is guided by this customized, all-inclusive project management tool from study launch through enrollment and monitoring to study close.
The clinical trial management system market is expected to grow due to the rapidly expanding healthcare IT industry, government support for research trials, initiatives by important companies, demand for decentralized clinical trials, and increased clinical studies. Medical research efforts are being promoted by government financing as well as investments are made by biotechnology and pharmaceutical companies for clinical trials. It is expected that, together with technical improvements, it will accelerate market growth. According to the World Health Organization (WHO), approximately 64,658 clinical trials were conducted globally in 2021, among which the Western Pacific region accounted for 16,860 clinical trials. This amount was significantly more than the trials that were completed in 2019. The growing number of clinical trials is expected to increase the demand for clinical trial management solutions in the global market. However, financial restrictions and a lack of information about clinical trial management systems might hamper the market growth.
COVID-19 Analysis
Biopharma companies and healthcare sectors globally have faced severe financial restraints due to the emergence of this pandemic. In this aspect, the clinical trial management system has proven to be quite beneficial and had a positive impact because it enables academic and industry researchers to monitor patients utilizing digitally connected platforms while also assisting in the organization & evaluation of clinical data for regulatory filings.
Segmentation
The Clinical Trial Management System Market has been segmented based on type, delivery model, component, end user, and region.
The global market for clinical trial management system, by type, has been segmented into enterprise CTMS and on-site CTMS.
The delivery model segment consists of web-based (hosted CTMS), licensed enterprise, and cloud-based CTMS (SaaS).
On the basis of component, the market has been segmented into software, service, and hardware.
The end users of the market have been segmented into pharmaceutical and biopharmaceutical companies, medical device manufacturers, contract research organizations, and others.
In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The clinical trial management system market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European clinical trial management system market has been segmented into Western Europe and Eastern Europe. Western Europe has been segmented into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The clinical trial management system market in Asia-Pacific has been classified as Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The clinical trial management system market in the Middle East & Africa has been divided into the Middle East and Africa.
Regional Market Summary
The Americas dominated the global market for a clinical trial management system owing to the increasing investments in research and development of CTMS by major companies and government organizations. In 2019, according to ClinicalTrials.gov database, there were total 322,282 studies registered for clinical trials, wherein and 34% cases registered from the US and 49% from other countries.
In 2021, Europe stood second in the global clinical trial management system market. The growing healthcare IT sector and high accuracy level of information provided by the clinical trial management system is expected to drive the growth of the market. Germany is expected to have the largest share in the European market for clinical trial management systems.
Asia-Pacific is expected to register the fastest growth in clinical trial management system market throughout the forecast period due to the growing customer base for CTMS solutions, growing demand for CMTS in the key markets around the globe, and the favorable government policies for the growth of healthcare IT sector in the region. The increasing sedentary lifestyle is countries in Asia-Pacific fuels the market growth in this region. Moreover, the presence of countries such as China, India, and Japan is expected to have positive impact on the market growth.
On the other hand, the Middle East and Africa held the least share in the global clinical trial management system market due to the lack of awareness and low income, especially within Africa.
Key Players
Some of the key players in the Global Clinical Trial Management System Market are Forte Research Systems Inc., eClinForce, Inc., Oracle, Medidata Solutions, iWeb Technologies, PAREXEL, Bioclinica, Bio-Optronics, IBM, Datatrak, Veeva Systems, DSG, Mastercontrol, ERT, Mednet Solutions, Arisglobal, DZS Software Solutions, and others.
Market Segmentation
Clinical Trial Management System Market, by Type
- Enterprise CTMS
- On-Site CTMS
Clinical Trial Management System Market, by Delivery Model
- Web-Based (Hosted CTMS)
- Licensed Enterprise
- Cloud-Based CTMS (SaaS)
Clinical Trial Management System Market, by Component
- Software
- Service
- Hardware
Clinical Trial Management System Market, by End User
- Pharmaceutical and Biopharmaceutical Companies
- Medical Device Manufacturers
- Contract Research Organizations
- Others
Recent Development
- In June 2022, Medidata, a Dassault Systèmes company, announced about technological improvements to solve challenges in clinical trial management. It will improve data oversight and reporting for contract research organizations (CROs) and sponsors.
- In April 2022, Veeva Systems announced that Bristol Myers Squibb integrated Veeva Vault CTMS internationally to support end-to-end clinical trial management.
- In February 2021, eClinical Solutions LLC, a provider of cloud-based software, announced the launch of the elluminate Clinical Trial Management System that accelerates digitalization and shortens cycle times for clinical data review.
Intended Audience
- Pharmaceutical Manufacturers and Suppliers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Contract Research Organizations (CROs)
- Government organizations
- Independent Research Laboratories
- Research and Development (R&D) Companies
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | USD 3.72 Billion |
| CAGR | 13.4% |
| Base Year | 2021 |
| Forecast Period | 2022-2030 |
| Historical Data | 2020 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Type, Component, End-User and Region |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Forte Research Systems Inc., eClinForce, Inc., Oracle, Medidata Solutions, iWeb Technologies, PAREXEL, Bioclinica, Bio-Optronics, IBM, Datatrak, Veeva Systems, DSG, Mastercontrol, ERT, Mednet Solutions, Arisglobal, DZS Software Solutions, and others |
| Key Market Opportunities | The rising frequency of long-lasting diseases and the rapid growth rate of healthcare service benefactors are likely to drive for the growth of the market |
| Key Market Drivers | The low battery life of mobile computers and reimbursement policies, are also expected to propel the growth of the market. |
Frequently Asked Questions (FAQ) :
The clinical trial management system market is expected to reach USD 3,720 million by 2030.
The clinical trial management system market was valued at USD 1.61 billion in 2021.
The clinical trial management system market is expected to exhibit a CAGR of 13.4% from 2022 to 2030.
Mednet Solutions, PAREXEL, iWeb Technologies, Medidata Solutions, IBM, ERT, eClinForce, Inc., Arisglobal, Forte Research Systems Inc., DSG, Oracle, DZS Software Solutions, Bioclinica, Bio-Optronics, Veeva Systems, Mastercontrol, and Datatrak are major players of the global clinical trial management system market.
Failure of clinical trials and the lengthy approval times of therapeutics are major challenges of the global clinical trial management system market.
The clinical trial management system market was valued at USD 1.61 billion in 2021.
